Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

8.52
Delayed Data
As of 4:00pm ET
 -0.13 / -1.50%
Today’s Change
8.31
Today|||52-Week Range
22.22
-33.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues915.88927.06985.39999.57
 
 
 
 
 
Depreciation And Amortization7.3K8.3K7.9K9.0K
 
 
 
 
 
 
Operating ExpensesGross Income-6.4K------
 
 
General Expenses4.4M4.4M5.8M4.6M
 
 
 
 
 
Other Operating Expenses179.5K229.9K0.000.00
 
 
 
Research And Development3.4M3.5M5.0M3.9M
 
 
 
 
 
Total Operating Expenses4.6M4.6M5.8M4.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-4.6M-5.8M-4.6M
 
 
 
 
 
Extraordinary Credit179.5K229.9K----
 
 
 
Other Expenses-470.8K104.8K-695.7K1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.9M-4.3M-6.5M-3.3M
 
 
 
 
 
Net Income-4.9M-4.3M-6.5M-3.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.8M9.4M9.9M12.3M
 
 
 
 
 
Shares To Calculate EPS Diluted8.8M9.4M--12.4M
 
 
 
 
 
Earnings Per ShareEPS-$0.55-$0.46-$0.69-$0.30
 
 
 
 
 
EPS Diluted-$0.55-$0.46-$0.69-$0.40